nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—ABCG2—gout	0.407	1	CbGaD
Erlotinib—UGT1A1—Naproxen—gout	0.0822	0.189	CbGbCtD
Erlotinib—UGT1A1—Indomethacin—gout	0.0543	0.125	CbGbCtD
Erlotinib—ALB—Naproxen—gout	0.0312	0.0715	CbGbCtD
Erlotinib—CYP2C8—Naproxen—gout	0.0241	0.0553	CbGbCtD
Erlotinib—ALB—Probenecid—gout	0.0211	0.0485	CbGbCtD
Erlotinib—ALB—Indomethacin—gout	0.0206	0.0473	CbGbCtD
Erlotinib—CYP1A2—Naproxen—gout	0.0186	0.0428	CbGbCtD
Erlotinib—ABCG2—Hydrocortisone—gout	0.0184	0.0422	CbGbCtD
Erlotinib—CYP2C8—Colchicine—gout	0.0182	0.0419	CbGbCtD
Erlotinib—CYP2C8—Probenecid—gout	0.0163	0.0375	CbGbCtD
Erlotinib—ALB—Prednisone—gout	0.0126	0.029	CbGbCtD
Erlotinib—ABCB1—Colchicine—gout	0.0123	0.0284	CbGbCtD
Erlotinib—ABCB1—Probenecid—gout	0.0111	0.0254	CbGbCtD
Erlotinib—ABCB1—Methylprednisolone—gout	0.0109	0.025	CbGbCtD
Erlotinib—ABCB1—Indomethacin—gout	0.0108	0.0247	CbGbCtD
Erlotinib—CYP3A5—Hydrocortisone—gout	0.0102	0.0234	CbGbCtD
Erlotinib—CYP2C8—Hydrocortisone—gout	0.0098	0.0225	CbGbCtD
Erlotinib—CYP3A4—Colchicine—gout	0.0074	0.017	CbGbCtD
Erlotinib—ABCB1—Prednisolone—gout	0.007	0.0161	CbGbCtD
Erlotinib—ABCB1—Hydrocortisone—gout	0.00663	0.0152	CbGbCtD
Erlotinib—CYP3A4—Probenecid—gout	0.00662	0.0152	CbGbCtD
Erlotinib—ABCB1—Prednisone—gout	0.00661	0.0152	CbGbCtD
Erlotinib—CYP3A4—Methylprednisolone—gout	0.00654	0.015	CbGbCtD
Erlotinib—CYP3A4—Prednisolone—gout	0.00419	0.00963	CbGbCtD
Erlotinib—CYP3A4—Hydrocortisone—gout	0.00397	0.00913	CbGbCtD
Erlotinib—CYP3A4—Prednisone—gout	0.00396	0.00909	CbGbCtD
Erlotinib—Vandetanib—ABCG2—gout	0.00149	0.513	CrCbGaD
Erlotinib—Gefitinib—ABCG2—gout	0.00142	0.487	CrCbGaD
Erlotinib—ABCB1—Abacavir transmembrane transport—ABCG2—gout	0.000374	0.0605	CbGpPWpGaD
Erlotinib—UGT1A1—Irinotecan Pathway—ABCG2—gout	0.000357	0.0579	CbGpPWpGaD
Erlotinib—ABL1—Factors involved in megakaryocyte development and platelet production—LRRC16A—gout	0.00024	0.0389	CbGpPWpGaD
Erlotinib—Dermatitis bullous—Prednisolone—gout	0.000223	0.0015	CcSEcCtD
Erlotinib—Dyspnoea—Indomethacin—gout	0.000222	0.00149	CcSEcCtD
Erlotinib—Nervous system disorder—Allopurinol—gout	0.000222	0.00149	CcSEcCtD
Erlotinib—Thrombocytopenia—Allopurinol—gout	0.000221	0.00149	CcSEcCtD
Erlotinib—Skin disorder—Allopurinol—gout	0.00022	0.00148	CcSEcCtD
Erlotinib—Dyspepsia—Indomethacin—gout	0.000219	0.00147	CcSEcCtD
Erlotinib—CYP3A5—Irinotecan Pathway—ABCG2—gout	0.000217	0.0352	CbGpPWpGaD
Erlotinib—Syncope—Naproxen—gout	0.000217	0.00146	CcSEcCtD
Erlotinib—Decreased appetite—Indomethacin—gout	0.000217	0.00146	CcSEcCtD
Erlotinib—Anorexia—Allopurinol—gout	0.000215	0.00145	CcSEcCtD
Erlotinib—Fatigue—Indomethacin—gout	0.000215	0.00144	CcSEcCtD
Erlotinib—ABCB1—Abacavir transport and metabolism—ABCG2—gout	0.000215	0.0348	CbGpPWpGaD
Erlotinib—Gastrointestinal pain—Colchicine—gout	0.000214	0.00144	CcSEcCtD
Erlotinib—Pain—Indomethacin—gout	0.000213	0.00143	CcSEcCtD
Erlotinib—Constipation—Indomethacin—gout	0.000213	0.00143	CcSEcCtD
Erlotinib—Loss of consciousness—Naproxen—gout	0.000213	0.00143	CcSEcCtD
Erlotinib—Cough—Naproxen—gout	0.000211	0.00142	CcSEcCtD
Erlotinib—Abdominal pain—Colchicine—gout	0.000207	0.00139	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Allopurinol—gout	0.000206	0.00138	CcSEcCtD
Erlotinib—Arthralgia—Naproxen—gout	0.000206	0.00138	CcSEcCtD
Erlotinib—Chest pain—Naproxen—gout	0.000206	0.00138	CcSEcCtD
Erlotinib—Myalgia—Naproxen—gout	0.000206	0.00138	CcSEcCtD
Erlotinib—Anxiety—Naproxen—gout	0.000205	0.00138	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Naproxen—gout	0.000204	0.00137	CcSEcCtD
Erlotinib—Insomnia—Allopurinol—gout	0.000204	0.00137	CcSEcCtD
Erlotinib—Skin exfoliation—Prednisone—gout	0.000204	0.00137	CcSEcCtD
Erlotinib—Gastrointestinal pain—Indomethacin—gout	0.000204	0.00137	CcSEcCtD
Erlotinib—Neuropathy—Prednisone—gout	0.0002	0.00135	CcSEcCtD
Erlotinib—Dyspepsia—Allopurinol—gout	0.000199	0.00134	CcSEcCtD
Erlotinib—Oedema—Naproxen—gout	0.000197	0.00133	CcSEcCtD
Erlotinib—Abdominal pain—Indomethacin—gout	0.000197	0.00132	CcSEcCtD
Erlotinib—Body temperature increased—Indomethacin—gout	0.000197	0.00132	CcSEcCtD
Erlotinib—Decreased appetite—Allopurinol—gout	0.000196	0.00132	CcSEcCtD
Erlotinib—Infection—Naproxen—gout	0.000196	0.00132	CcSEcCtD
Erlotinib—Dry skin—Prednisolone—gout	0.000195	0.00131	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Allopurinol—gout	0.000195	0.00131	CcSEcCtD
Erlotinib—Shock—Naproxen—gout	0.000194	0.00131	CcSEcCtD
Erlotinib—Nervous system disorder—Naproxen—gout	0.000194	0.0013	CcSEcCtD
Erlotinib—Constipation—Allopurinol—gout	0.000193	0.0013	CcSEcCtD
Erlotinib—Pain—Allopurinol—gout	0.000193	0.0013	CcSEcCtD
Erlotinib—Thrombocytopenia—Naproxen—gout	0.000193	0.0013	CcSEcCtD
Erlotinib—Skin disorder—Naproxen—gout	0.000192	0.00129	CcSEcCtD
Erlotinib—Dry skin—Hydrocortisone—gout	0.000191	0.00128	CcSEcCtD
Erlotinib—Hypokalaemia—Hydrocortisone—gout	0.00019	0.00127	CcSEcCtD
Erlotinib—Anorexia—Naproxen—gout	0.000188	0.00126	CcSEcCtD
Erlotinib—Asthenia—Colchicine—gout	0.000188	0.00126	CcSEcCtD
Erlotinib—Sepsis—Prednisone—gout	0.000185	0.00125	CcSEcCtD
Erlotinib—Gastrointestinal pain—Allopurinol—gout	0.000185	0.00124	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Hydrocortisone—gout	0.000184	0.00123	CcSEcCtD
Erlotinib—Pancreatitis—Prednisolone—gout	0.000181	0.00121	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Naproxen—gout	0.00018	0.00121	CcSEcCtD
Erlotinib—Diarrhoea—Colchicine—gout	0.000179	0.00121	CcSEcCtD
Erlotinib—Asthenia—Indomethacin—gout	0.000179	0.0012	CcSEcCtD
Erlotinib—Abdominal pain—Allopurinol—gout	0.000179	0.0012	CcSEcCtD
Erlotinib—Body temperature increased—Allopurinol—gout	0.000179	0.0012	CcSEcCtD
Erlotinib—Insomnia—Naproxen—gout	0.000178	0.0012	CcSEcCtD
Erlotinib—Pancreatitis—Hydrocortisone—gout	0.000176	0.00119	CcSEcCtD
Erlotinib—Pruritus—Indomethacin—gout	0.000176	0.00118	CcSEcCtD
Erlotinib—Dyspnoea—Naproxen—gout	0.000176	0.00118	CcSEcCtD
Erlotinib—Dyspepsia—Naproxen—gout	0.000174	0.00117	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Methylprednisolone—gout	0.000173	0.00116	CcSEcCtD
Erlotinib—Decreased appetite—Naproxen—gout	0.000172	0.00115	CcSEcCtD
Erlotinib—Diarrhoea—Indomethacin—gout	0.00017	0.00115	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Naproxen—gout	0.00017	0.00115	CcSEcCtD
Erlotinib—Fatigue—Naproxen—gout	0.00017	0.00114	CcSEcCtD
Erlotinib—Pain—Naproxen—gout	0.000169	0.00113	CcSEcCtD
Erlotinib—Constipation—Naproxen—gout	0.000169	0.00113	CcSEcCtD
Erlotinib—Vomiting—Colchicine—gout	0.000167	0.00112	CcSEcCtD
Erlotinib—Pancreatitis—Methylprednisolone—gout	0.000166	0.00111	CcSEcCtD
Erlotinib—Rash—Colchicine—gout	0.000165	0.00111	CcSEcCtD
Erlotinib—Dermatitis—Colchicine—gout	0.000165	0.00111	CcSEcCtD
Erlotinib—Dizziness—Indomethacin—gout	0.000165	0.00111	CcSEcCtD
Erlotinib—Headache—Colchicine—gout	0.000164	0.0011	CcSEcCtD
Erlotinib—JAK3—Hemostasis—LRRC16A—gout	0.000164	0.0266	CbGpPWpGaD
Erlotinib—SLCO2B1—SLC-mediated transmembrane transport—SLC17A1—gout	0.000163	0.0264	CbGpPWpGaD
Erlotinib—SLCO2B1—SLC-mediated transmembrane transport—SLC22A11—gout	0.000163	0.0264	CbGpPWpGaD
Erlotinib—Weight decreased—Hydrocortisone—gout	0.000163	0.00109	CcSEcCtD
Erlotinib—Asthenia—Allopurinol—gout	0.000162	0.00109	CcSEcCtD
Erlotinib—Acute coronary syndrome—Prednisolone—gout	0.000162	0.00109	CcSEcCtD
Erlotinib—Gastrointestinal pain—Naproxen—gout	0.000161	0.00108	CcSEcCtD
Erlotinib—Neuropathy peripheral—Prednisolone—gout	0.000161	0.00108	CcSEcCtD
Erlotinib—Myocardial infarction—Prednisolone—gout	0.000161	0.00108	CcSEcCtD
Erlotinib—Infestation—Hydrocortisone—gout	0.00016	0.00108	CcSEcCtD
Erlotinib—Infestation NOS—Hydrocortisone—gout	0.00016	0.00108	CcSEcCtD
Erlotinib—Pruritus—Allopurinol—gout	0.00016	0.00108	CcSEcCtD
Erlotinib—Conjunctivitis—Prednisolone—gout	0.00016	0.00107	CcSEcCtD
Erlotinib—Vomiting—Indomethacin—gout	0.000158	0.00106	CcSEcCtD
Erlotinib—Acute coronary syndrome—Hydrocortisone—gout	0.000158	0.00106	CcSEcCtD
Erlotinib—Myocardial infarction—Hydrocortisone—gout	0.000157	0.00106	CcSEcCtD
Erlotinib—Neuropathy peripheral—Hydrocortisone—gout	0.000157	0.00106	CcSEcCtD
Erlotinib—Rash—Indomethacin—gout	0.000157	0.00106	CcSEcCtD
Erlotinib—Dermatitis—Indomethacin—gout	0.000157	0.00105	CcSEcCtD
Erlotinib—Headache—Indomethacin—gout	0.000156	0.00105	CcSEcCtD
Erlotinib—Body temperature increased—Naproxen—gout	0.000156	0.00105	CcSEcCtD
Erlotinib—Abdominal pain—Naproxen—gout	0.000156	0.00105	CcSEcCtD
Erlotinib—Nausea—Colchicine—gout	0.000156	0.00105	CcSEcCtD
Erlotinib—Gastrointestinal haemorrhage—Prednisone—gout	0.000155	0.00104	CcSEcCtD
Erlotinib—Diarrhoea—Allopurinol—gout	0.000155	0.00104	CcSEcCtD
Erlotinib—Infestation—Methylprednisolone—gout	0.000151	0.00101	CcSEcCtD
Erlotinib—Infestation NOS—Methylprednisolone—gout	0.000151	0.00101	CcSEcCtD
Erlotinib—Dizziness—Allopurinol—gout	0.000149	0.001	CcSEcCtD
Erlotinib—Acute coronary syndrome—Methylprednisolone—gout	0.000149	0.000999	CcSEcCtD
Erlotinib—Haemoglobin—Prednisolone—gout	0.000148	0.000997	CcSEcCtD
Erlotinib—Nausea—Indomethacin—gout	0.000148	0.000995	CcSEcCtD
Erlotinib—Myocardial infarction—Methylprednisolone—gout	0.000148	0.000994	CcSEcCtD
Erlotinib—Neuropathy peripheral—Methylprednisolone—gout	0.000148	0.000994	CcSEcCtD
Erlotinib—Haemorrhage—Prednisolone—gout	0.000147	0.000992	CcSEcCtD
Erlotinib—Haemoglobin—Hydrocortisone—gout	0.000145	0.000973	CcSEcCtD
Erlotinib—Haemorrhage—Hydrocortisone—gout	0.000144	0.000968	CcSEcCtD
Erlotinib—Vomiting—Allopurinol—gout	0.000144	0.000966	CcSEcCtD
Erlotinib—Rash—Allopurinol—gout	0.000142	0.000958	CcSEcCtD
Erlotinib—Dermatitis—Allopurinol—gout	0.000142	0.000957	CcSEcCtD
Erlotinib—Dry skin—Prednisone—gout	0.000142	0.000955	CcSEcCtD
Erlotinib—Headache—Allopurinol—gout	0.000142	0.000952	CcSEcCtD
Erlotinib—Asthenia—Naproxen—gout	0.000142	0.000952	CcSEcCtD
Erlotinib—Connective tissue disorder—Hydrocortisone—gout	0.000142	0.000952	CcSEcCtD
Erlotinib—Hypokalaemia—Prednisone—gout	0.000141	0.000948	CcSEcCtD
Erlotinib—Pruritus—Naproxen—gout	0.00014	0.000939	CcSEcCtD
Erlotinib—ABL1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.00014	0.0226	CbGpPWpGaD
Erlotinib—Alanine aminotransferase increased—Prednisone—gout	0.000137	0.000919	CcSEcCtD
Erlotinib—Haemoglobin—Methylprednisolone—gout	0.000136	0.000915	CcSEcCtD
Erlotinib—Haemorrhage—Methylprednisolone—gout	0.000135	0.00091	CcSEcCtD
Erlotinib—Diarrhoea—Naproxen—gout	0.000135	0.000908	CcSEcCtD
Erlotinib—Eye disorder—Hydrocortisone—gout	0.000135	0.000905	CcSEcCtD
Erlotinib—Nausea—Allopurinol—gout	0.000134	0.000903	CcSEcCtD
Erlotinib—Connective tissue disorder—Methylprednisolone—gout	0.000133	0.000894	CcSEcCtD
Erlotinib—Arrhythmia—Prednisolone—gout	0.000132	0.000886	CcSEcCtD
Erlotinib—Pancreatitis—Prednisone—gout	0.000131	0.000883	CcSEcCtD
Erlotinib—Dizziness—Naproxen—gout	0.00013	0.000877	CcSEcCtD
Erlotinib—Arrhythmia—Hydrocortisone—gout	0.000129	0.000865	CcSEcCtD
Erlotinib—Erythema—Prednisolone—gout	0.000128	0.000863	CcSEcCtD
Erlotinib—JAK3—Signaling by Interleukins—CASP1—gout	0.000127	0.0205	CbGpPWpGaD
Erlotinib—Eye disorder—Methylprednisolone—gout	0.000126	0.00085	CcSEcCtD
Erlotinib—Mental disorder—Hydrocortisone—gout	0.000126	0.000848	CcSEcCtD
Erlotinib—Vomiting—Naproxen—gout	0.000125	0.000844	CcSEcCtD
Erlotinib—Erythema—Hydrocortisone—gout	0.000125	0.000843	CcSEcCtD
Erlotinib—Malnutrition—Hydrocortisone—gout	0.000125	0.000843	CcSEcCtD
Erlotinib—Neutropenia—Prednisone—gout	0.000125	0.000842	CcSEcCtD
Erlotinib—Rash—Naproxen—gout	0.000124	0.000836	CcSEcCtD
Erlotinib—Dermatitis—Naproxen—gout	0.000124	0.000836	CcSEcCtD
Erlotinib—Headache—Naproxen—gout	0.000124	0.000831	CcSEcCtD
Erlotinib—SLCO2B1—SLC-mediated transmembrane transport—SLC22A12—gout	0.000123	0.02	CbGpPWpGaD
Erlotinib—JAK3—Signaling by Interleukins—IL1RN—gout	0.000123	0.0199	CbGpPWpGaD
Erlotinib—Mediastinal disorder—Methylprednisolone—gout	0.000122	0.00082	CcSEcCtD
Erlotinib—Weight decreased—Prednisone—gout	0.000121	0.000814	CcSEcCtD
Erlotinib—Arrhythmia—Methylprednisolone—gout	0.000121	0.000813	CcSEcCtD
Erlotinib—Depression—Prednisone—gout	0.000119	0.0008	CcSEcCtD
Erlotinib—Mental disorder—Methylprednisolone—gout	0.000119	0.000797	CcSEcCtD
Erlotinib—MKNK1—MAPK Signaling Pathway—CASP1—gout	0.000118	0.0191	CbGpPWpGaD
Erlotinib—Erythema—Methylprednisolone—gout	0.000118	0.000792	CcSEcCtD
Erlotinib—Malnutrition—Methylprednisolone—gout	0.000118	0.000792	CcSEcCtD
Erlotinib—Acute coronary syndrome—Prednisone—gout	0.000118	0.000791	CcSEcCtD
Erlotinib—Nausea—Naproxen—gout	0.000117	0.000788	CcSEcCtD
Erlotinib—Neuropathy peripheral—Prednisone—gout	0.000117	0.000787	CcSEcCtD
Erlotinib—Myocardial infarction—Prednisone—gout	0.000117	0.000787	CcSEcCtD
Erlotinib—Syncope—Prednisolone—gout	0.000115	0.000774	CcSEcCtD
Erlotinib—SLCO2B1—SLC-mediated transmembrane transport—SLC2A9—gout	0.000115	0.0186	CbGpPWpGaD
Erlotinib—Loss of consciousness—Prednisolone—gout	0.000113	0.000759	CcSEcCtD
Erlotinib—Syncope—Hydrocortisone—gout	0.000112	0.000756	CcSEcCtD
Erlotinib—Loss of consciousness—Hydrocortisone—gout	0.00011	0.000741	CcSEcCtD
Erlotinib—Haemoglobin—Prednisone—gout	0.000108	0.000724	CcSEcCtD
Erlotinib—Haemorrhage—Prednisone—gout	0.000107	0.000721	CcSEcCtD
Erlotinib—Myalgia—Hydrocortisone—gout	0.000107	0.000718	CcSEcCtD
Erlotinib—Anxiety—Hydrocortisone—gout	0.000106	0.000715	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	0.000106	0.000713	CcSEcCtD
Erlotinib—Syncope—Methylprednisolone—gout	0.000106	0.00071	CcSEcCtD
Erlotinib—Connective tissue disorder—Prednisone—gout	0.000105	0.000708	CcSEcCtD
Erlotinib—Oedema—Prednisolone—gout	0.000105	0.000705	CcSEcCtD
Erlotinib—UGT1A1—NRF2 pathway—SLC2A9—gout	0.000104	0.0169	CbGpPWpGaD
Erlotinib—Loss of consciousness—Methylprednisolone—gout	0.000104	0.000696	CcSEcCtD
Erlotinib—Shock—Prednisolone—gout	0.000103	0.000693	CcSEcCtD
Erlotinib—Oedema—Hydrocortisone—gout	0.000102	0.000688	CcSEcCtD
Erlotinib—Infection—Hydrocortisone—gout	0.000102	0.000684	CcSEcCtD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—SLC17A3—gout	0.000102	0.0164	CbGpPWpGaD
Erlotinib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000101	0.0164	CbGpPWpGaD
Erlotinib—Shock—Hydrocortisone—gout	0.000101	0.000677	CcSEcCtD
Erlotinib—EGFR—Syndecan-3-mediated signaling events—POMC—gout	0.000101	0.0163	CbGpPWpGaD
Erlotinib—Nervous system disorder—Hydrocortisone—gout	0.0001	0.000675	CcSEcCtD
Erlotinib—Myalgia—Methylprednisolone—gout	0.0001	0.000674	CcSEcCtD
Erlotinib—Arthralgia—Methylprednisolone—gout	0.0001	0.000674	CcSEcCtD
Erlotinib—Eye disorder—Prednisone—gout	0.0001	0.000673	CcSEcCtD
Erlotinib—Anxiety—Methylprednisolone—gout	0.0001	0.000672	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	9.96e-05	0.00067	CcSEcCtD
Erlotinib—Skin disorder—Hydrocortisone—gout	9.94e-05	0.000668	CcSEcCtD
Erlotinib—Anorexia—Hydrocortisone—gout	9.76e-05	0.000656	CcSEcCtD
Erlotinib—CYP1B1—Endogenous sterols—POMC—gout	9.6e-05	0.0155	CbGpPWpGaD
Erlotinib—Arrhythmia—Prednisone—gout	9.57e-05	0.000644	CcSEcCtD
Erlotinib—Infection—Methylprednisolone—gout	9.55e-05	0.000642	CcSEcCtD
Erlotinib—Insomnia—Prednisolone—gout	9.48e-05	0.000637	CcSEcCtD
Erlotinib—Alopecia—Prednisone—gout	9.47e-05	0.000637	CcSEcCtD
Erlotinib—Shock—Methylprednisolone—gout	9.46e-05	0.000636	CcSEcCtD
Erlotinib—Nervous system disorder—Methylprednisolone—gout	9.43e-05	0.000634	CcSEcCtD
Erlotinib—Mental disorder—Prednisone—gout	9.39e-05	0.000631	CcSEcCtD
Erlotinib—Skin disorder—Methylprednisolone—gout	9.34e-05	0.000628	CcSEcCtD
Erlotinib—Malnutrition—Prednisone—gout	9.33e-05	0.000627	CcSEcCtD
Erlotinib—Erythema—Prednisone—gout	9.33e-05	0.000627	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Hydrocortisone—gout	9.32e-05	0.000627	CcSEcCtD
Erlotinib—Insomnia—Hydrocortisone—gout	9.26e-05	0.000622	CcSEcCtD
Erlotinib—Dyspepsia—Hydrocortisone—gout	9.01e-05	0.000606	CcSEcCtD
Erlotinib—Pain—Prednisolone—gout	8.96e-05	0.000602	CcSEcCtD
Erlotinib—Decreased appetite—Hydrocortisone—gout	8.9e-05	0.000598	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Hydrocortisone—gout	8.84e-05	0.000594	CcSEcCtD
Erlotinib—Fatigue—Hydrocortisone—gout	8.82e-05	0.000593	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methylprednisolone—gout	8.76e-05	0.000589	CcSEcCtD
Erlotinib—Pain—Hydrocortisone—gout	8.75e-05	0.000588	CcSEcCtD
Erlotinib—Insomnia—Methylprednisolone—gout	8.7e-05	0.000585	CcSEcCtD
Erlotinib—Dyspepsia—Methylprednisolone—gout	8.46e-05	0.000569	CcSEcCtD
Erlotinib—ABL1—Hemostasis—LRRC16A—gout	8.4e-05	0.0136	CbGpPWpGaD
Erlotinib—Gastrointestinal pain—Hydrocortisone—gout	8.37e-05	0.000563	CcSEcCtD
Erlotinib—Syncope—Prednisone—gout	8.37e-05	0.000563	CcSEcCtD
Erlotinib—Fatigue—Methylprednisolone—gout	8.29e-05	0.000557	CcSEcCtD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—SLC22A11—gout	8.28e-05	0.0134	CbGpPWpGaD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—SLC17A1—gout	8.28e-05	0.0134	CbGpPWpGaD
Erlotinib—Loss of consciousness—Prednisone—gout	8.2e-05	0.000551	CcSEcCtD
Erlotinib—Abdominal pain—Hydrocortisone—gout	8.09e-05	0.000544	CcSEcCtD
Erlotinib—Body temperature increased—Hydrocortisone—gout	8.09e-05	0.000544	CcSEcCtD
Erlotinib—Arthralgia—Prednisone—gout	7.94e-05	0.000534	CcSEcCtD
Erlotinib—Myalgia—Prednisone—gout	7.94e-05	0.000534	CcSEcCtD
Erlotinib—Anxiety—Prednisone—gout	7.92e-05	0.000532	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	7.89e-05	0.00053	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methylprednisolone—gout	7.86e-05	0.000529	CcSEcCtD
Erlotinib—Oedema—Prednisone—gout	7.61e-05	0.000512	CcSEcCtD
Erlotinib—Abdominal pain—Methylprednisolone—gout	7.6e-05	0.000511	CcSEcCtD
Erlotinib—Infection—Prednisone—gout	7.56e-05	0.000509	CcSEcCtD
Erlotinib—Shock—Prednisone—gout	7.49e-05	0.000504	CcSEcCtD
Erlotinib—Nervous system disorder—Prednisone—gout	7.47e-05	0.000502	CcSEcCtD
Erlotinib—Skin disorder—Prednisone—gout	7.4e-05	0.000497	CcSEcCtD
Erlotinib—Asthenia—Hydrocortisone—gout	7.34e-05	0.000494	CcSEcCtD
Erlotinib—MKNK1—Disease—PRPS1—gout	7.3e-05	0.0118	CbGpPWpGaD
Erlotinib—MKNK1—Disease—PRPS2—gout	7.3e-05	0.0118	CbGpPWpGaD
Erlotinib—Anorexia—Prednisone—gout	7.26e-05	0.000488	CcSEcCtD
Erlotinib—MAP2K5—MAPK Signaling Pathway—CASP1—gout	7.25e-05	0.0117	CbGpPWpGaD
Erlotinib—Pruritus—Hydrocortisone—gout	7.24e-05	0.000487	CcSEcCtD
Erlotinib—Diarrhoea—Hydrocortisone—gout	7e-05	0.000471	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Prednisone—gout	6.94e-05	0.000466	CcSEcCtD
Erlotinib—Dizziness—Prednisolone—gout	6.93e-05	0.000466	CcSEcCtD
Erlotinib—Asthenia—Methylprednisolone—gout	6.9e-05	0.000464	CcSEcCtD
Erlotinib—Insomnia—Prednisone—gout	6.89e-05	0.000463	CcSEcCtD
Erlotinib—Pruritus—Methylprednisolone—gout	6.8e-05	0.000457	CcSEcCtD
Erlotinib—Dizziness—Hydrocortisone—gout	6.77e-05	0.000455	CcSEcCtD
Erlotinib—Dyspepsia—Prednisone—gout	6.7e-05	0.000451	CcSEcCtD
Erlotinib—Decreased appetite—Prednisone—gout	6.62e-05	0.000445	CcSEcCtD
Erlotinib—Rash—Prednisolone—gout	6.61e-05	0.000444	CcSEcCtD
Erlotinib—Dermatitis—Prednisolone—gout	6.6e-05	0.000444	CcSEcCtD
Erlotinib—Diarrhoea—Methylprednisolone—gout	6.58e-05	0.000442	CcSEcCtD
Erlotinib—Fatigue—Prednisone—gout	6.56e-05	0.000441	CcSEcCtD
Erlotinib—Headache—Prednisolone—gout	6.56e-05	0.000441	CcSEcCtD
Erlotinib—Constipation—Prednisone—gout	6.51e-05	0.000438	CcSEcCtD
Erlotinib—Vomiting—Hydrocortisone—gout	6.51e-05	0.000437	CcSEcCtD
Erlotinib—Rash—Hydrocortisone—gout	6.45e-05	0.000434	CcSEcCtD
Erlotinib—Dermatitis—Hydrocortisone—gout	6.45e-05	0.000433	CcSEcCtD
Erlotinib—Headache—Hydrocortisone—gout	6.41e-05	0.000431	CcSEcCtD
Erlotinib—Dizziness—Methylprednisolone—gout	6.36e-05	0.000427	CcSEcCtD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—SLC22A12—gout	6.27e-05	0.0102	CbGpPWpGaD
Erlotinib—Gastrointestinal pain—Prednisone—gout	6.23e-05	0.000419	CcSEcCtD
Erlotinib—Nausea—Prednisolone—gout	6.22e-05	0.000418	CcSEcCtD
Erlotinib—Vomiting—Methylprednisolone—gout	6.11e-05	0.000411	CcSEcCtD
Erlotinib—Nausea—Hydrocortisone—gout	6.08e-05	0.000409	CcSEcCtD
Erlotinib—Rash—Methylprednisolone—gout	6.06e-05	0.000408	CcSEcCtD
Erlotinib—Dermatitis—Methylprednisolone—gout	6.06e-05	0.000407	CcSEcCtD
Erlotinib—Headache—Methylprednisolone—gout	6.02e-05	0.000405	CcSEcCtD
Erlotinib—Abdominal pain—Prednisone—gout	6.02e-05	0.000405	CcSEcCtD
Erlotinib—Body temperature increased—Prednisone—gout	6.02e-05	0.000405	CcSEcCtD
Erlotinib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	6.02e-05	0.00975	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—CASP1—gout	5.91e-05	0.00957	CbGpPWpGaD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—SLC2A9—gout	5.83e-05	0.00945	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—IL1RN—gout	5.72e-05	0.00927	CbGpPWpGaD
Erlotinib—Nausea—Methylprednisolone—gout	5.71e-05	0.000384	CcSEcCtD
Erlotinib—Asthenia—Prednisone—gout	5.46e-05	0.000367	CcSEcCtD
Erlotinib—Pruritus—Prednisone—gout	5.39e-05	0.000362	CcSEcCtD
Erlotinib—Diarrhoea—Prednisone—gout	5.21e-05	0.00035	CcSEcCtD
Erlotinib—Dizziness—Prednisone—gout	5.04e-05	0.000339	CcSEcCtD
Erlotinib—ABCG2—Transmembrane transport of small molecules—SLC17A3—gout	4.93e-05	0.00799	CbGpPWpGaD
Erlotinib—ALB—SLC-mediated transmembrane transport—SLC17A1—gout	4.88e-05	0.00791	CbGpPWpGaD
Erlotinib—ALB—SLC-mediated transmembrane transport—SLC22A11—gout	4.88e-05	0.00791	CbGpPWpGaD
Erlotinib—Vomiting—Prednisone—gout	4.84e-05	0.000326	CcSEcCtD
Erlotinib—Rash—Prednisone—gout	4.8e-05	0.000323	CcSEcCtD
Erlotinib—Dermatitis—Prednisone—gout	4.8e-05	0.000322	CcSEcCtD
Erlotinib—Headache—Prednisone—gout	4.77e-05	0.000321	CcSEcCtD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	4.74e-05	0.00768	CbGpPWpGaD
Erlotinib—Nausea—Prednisone—gout	4.52e-05	0.000304	CcSEcCtD
Erlotinib—EGFR—Direct p53 effectors—CASP1—gout	4.5e-05	0.00729	CbGpPWpGaD
Erlotinib—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—gout	4.46e-05	0.00722	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—LRRC16A—gout	4.14e-05	0.0067	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—SLC22A11—gout	4.02e-05	0.00651	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—SLC17A1—gout	4.02e-05	0.00651	CbGpPWpGaD
Erlotinib—JAK3—Immune System—NLRP3—gout	3.95e-05	0.0064	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—CASP1—gout	3.89e-05	0.0063	CbGpPWpGaD
Erlotinib—ALB—SLC-mediated transmembrane transport—SLC22A12—gout	3.7e-05	0.00599	CbGpPWpGaD
Erlotinib—CYP1B1—Phase 1 - Functionalization of compounds—POMC—gout	3.61e-05	0.00585	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—NLRP3—gout	3.47e-05	0.00563	CbGpPWpGaD
Erlotinib—ALB—SLC-mediated transmembrane transport—SLC2A9—gout	3.44e-05	0.00557	CbGpPWpGaD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—ABCG2—gout	3.06e-05	0.00496	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—SLC22A12—gout	3.05e-05	0.00494	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC17A3—gout	3.04e-05	0.00493	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—NLRP3—gout	2.97e-05	0.00481	CbGpPWpGaD
Erlotinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—gout	2.9e-05	0.0047	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—SLC2A9—gout	2.83e-05	0.00459	CbGpPWpGaD
Erlotinib—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—gout	2.74e-05	0.00444	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—BCKDHA—gout	2.72e-05	0.00441	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	2.67e-05	0.00432	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—BCKDHA—gout	2.54e-05	0.00411	CbGpPWpGaD
Erlotinib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	2.52e-05	0.00407	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC22A11—gout	2.48e-05	0.00402	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC17A1—gout	2.48e-05	0.00402	CbGpPWpGaD
Erlotinib—EGFR—Disease—PRPS2—gout	2.41e-05	0.0039	CbGpPWpGaD
Erlotinib—EGFR—Disease—PRPS1—gout	2.41e-05	0.0039	CbGpPWpGaD
Erlotinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—gout	2.35e-05	0.00381	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—BCKDHA—gout	2.31e-05	0.00374	CbGpPWpGaD
Erlotinib—CYP1A1—Phase 1 - Functionalization of compounds—POMC—gout	2.22e-05	0.0036	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PRPS2—gout	2.22e-05	0.0036	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—HPRT1—gout	2.22e-05	0.0036	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PRPS1—gout	2.22e-05	0.0036	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	2.17e-05	0.00352	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	2.17e-05	0.00352	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PRPS2—gout	2.07e-05	0.00335	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—HPRT1—gout	2.07e-05	0.00335	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PRPS1—gout	2.07e-05	0.00335	CbGpPWpGaD
Erlotinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	2.07e-05	0.00335	CbGpPWpGaD
Erlotinib—UGT1A1—Biological oxidations—POMC—gout	2.06e-05	0.00333	CbGpPWpGaD
Erlotinib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	2.04e-05	0.0033	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NLRP3—gout	2.02e-05	0.00328	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CASP1—gout	1.93e-05	0.00313	CbGpPWpGaD
Erlotinib—CYP1B1—Biological oxidations—POMC—gout	1.92e-05	0.00311	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PRPS1—gout	1.88e-05	0.00305	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PRPS2—gout	1.88e-05	0.00305	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—HPRT1—gout	1.88e-05	0.00305	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC22A12—gout	1.88e-05	0.00305	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL1RN—gout	1.87e-05	0.00303	CbGpPWpGaD
Erlotinib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—gout	1.75e-05	0.00283	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC2A9—gout	1.75e-05	0.00283	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NLRP3—gout	1.73e-05	0.0028	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CASP1—gout	1.7e-05	0.00275	CbGpPWpGaD
Erlotinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	1.67e-05	0.00271	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—BCKDHA—gout	1.66e-05	0.00268	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	1.65e-05	0.00267	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—BCKDHA—gout	1.56e-05	0.00253	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	1.53e-05	0.00248	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CASP1—gout	1.45e-05	0.00235	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—BCKDHA—gout	1.43e-05	0.00232	CbGpPWpGaD
Erlotinib—ALB—Metabolism—BCKDHA—gout	1.43e-05	0.00231	CbGpPWpGaD
Erlotinib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—gout	1.42e-05	0.0023	CbGpPWpGaD
Erlotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	1.35e-05	0.00219	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PRPS1—gout	1.35e-05	0.00219	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PRPS2—gout	1.35e-05	0.00219	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—HPRT1—gout	1.35e-05	0.00219	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—HPRT1—gout	1.28e-05	0.00207	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PRPS2—gout	1.28e-05	0.00207	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PRPS1—gout	1.28e-05	0.00207	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—POMC—gout	1.25e-05	0.00203	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—BCKDHA—gout	1.25e-05	0.00202	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—POMC—gout	1.18e-05	0.00191	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—BCKDHA—gout	1.18e-05	0.00191	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PRPS1—gout	1.17e-05	0.00189	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—HPRT1—gout	1.17e-05	0.00189	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PRPS2—gout	1.17e-05	0.00189	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PRPS1—gout	1.16e-05	0.00188	CbGpPWpGaD
Erlotinib—ALB—Metabolism—HPRT1—gout	1.16e-05	0.00188	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PRPS2—gout	1.16e-05	0.00188	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—POMC—gout	1.14e-05	0.00185	CbGpPWpGaD
Erlotinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	1.09e-05	0.00177	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—POMC—gout	1.08e-05	0.00175	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—POMC—gout	1.03e-05	0.00168	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PRPS1—gout	1.02e-05	0.00165	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PRPS2—gout	1.02e-05	0.00165	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—HPRT1—gout	1.02e-05	0.00165	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—BCKDHA—gout	9.97e-06	0.00162	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CASP1—gout	9.88e-06	0.0016	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PRPS1—gout	9.6e-06	0.00155	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PRPS2—gout	9.6e-06	0.00155	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HPRT1—gout	9.6e-06	0.00155	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1RN—gout	9.57e-06	0.00155	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ABCG2—gout	9.18e-06	0.00149	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—POMC—gout	8.89e-06	0.00144	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CASP1—gout	8.44e-06	0.00137	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ABCG2—gout	8.22e-06	0.00133	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1RN—gout	8.18e-06	0.00132	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PRPS1—gout	8.13e-06	0.00132	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HPRT1—gout	8.13e-06	0.00132	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PRPS2—gout	8.13e-06	0.00132	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—POMC—gout	8.11e-06	0.00131	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	8.05e-06	0.0013	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—BCKDHA—gout	7.7e-06	0.00125	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ABCG2—gout	7.66e-06	0.00124	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—POMC—gout	7.53e-06	0.00122	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—POMC—gout	7.37e-06	0.00119	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PRPS1—gout	6.27e-06	0.00102	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HPRT1—gout	6.27e-06	0.00102	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PRPS2—gout	6.27e-06	0.00102	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—POMC—gout	6.11e-06	0.00099	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—POMC—gout	5.81e-06	0.000942	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ABCG2—gout	4.99e-06	0.000809	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—POMC—gout	4.98e-06	0.000807	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ABCG2—gout	4.72e-06	0.000764	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—gout	4.54e-06	0.000735	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—POMC—gout	4.53e-06	0.000733	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCG2—gout	4.33e-06	0.000701	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCG2—gout	4.3e-06	0.000697	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	4.16e-06	0.000674	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—POMC—gout	4.14e-06	0.00067	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ABCG2—gout	3.77e-06	0.000611	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCG2—gout	3.55e-06	0.000575	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—POMC—gout	3.52e-06	0.00057	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—POMC—gout	3.28e-06	0.000532	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCG2—gout	3.01e-06	0.000487	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—POMC—gout	2.99e-06	0.000484	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—gout	2.89e-06	0.000469	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—POMC—gout	2.67e-06	0.000433	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCG2—gout	2.32e-06	0.000376	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—gout	2.14e-06	0.000346	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—gout	2.02e-06	0.000327	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—gout	1.85e-06	0.0003	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—gout	1.84e-06	0.000298	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—gout	1.61e-06	0.000261	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—gout	1.52e-06	0.000246	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—gout	1.29e-06	0.000209	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—gout	9.94e-07	0.000161	CbGpPWpGaD
